BSX Filing
4Filing Date: May 11, 2026
BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001225208-26-005114open_in_new
Total Value$0
Trades1
Insiders1
Transaction Details
WICHMANN DAVID S
Director·Direct
Grant · Acquire
Common Stock
Shares+3.80K
Price$0.00
Total Value$0
Shares Owned After45.38K
Transaction DateMay 7, 2026
Footnotes ▸
Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
Post-Transaction Holdings
WICHMANN DAVID S
| Security | Shares | Change |
|---|---|---|
| Common Stock | 45.38K | +3.80K (9.14%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-07
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
--- Reporting Owner ---
Name: WICHMANN DAVID S
CIK: 0001268489
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-07 | Code: A (Grant or award)
Shares: +3,800 | Price: $0.00
Shares Owned After: 45,382 | Ownership: D (Direct)
Footnotes:
[F1] Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
--- Footnotes (Complete Index) ---
F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
--- Signature ---
/s/ /s/ Susan Thompson, Attorney-in-Fact (2026-05-11)